Literature DB >> 12505804

Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders.

Lawrence S Kegeles1, Kevin M Malone, Mark Slifstein, Steven P Ellis, Eric Xanthopoulos, John G Keilp, Carl Campbell, Maria Oquendo, Ronald L Van Heertum, J John Mann.   

Abstract

OBJECTIVE: In subjects with mood disorders, positron emission tomography (PET) with [(18)F]fluorodeoxyglucose has shown prefrontal cortical metabolism deficits, including in a subgenual region in subjects with familial illness. The authors applied a dl-fenfluramine challenge method to study metabolic response in this region to serotonergic challenge in familial major depression.
METHOD: The study group consisted of 19 depressed subjects with major depressive disorder or bipolar disorder, all of whom had at least one first-degree relative with history of major depression, and 10 healthy volunteers with similar age and gender distributions. PET images were acquired under placebo and challenge conditions, and volumetric MRI scans were also obtained. Group comparisons of metabolic and volumetric data were performed. Ratings of acute mood change during serotonergic challenge were compared with the imaging data.
RESULTS: Within Brodmann's area 32, a glucose metabolism deficit in the depressed subjects on placebo day was observed by voxel-level analysis, but no volumetric deficit was found in the subgenual regions examined. Under challenge, both groups suppressed metabolism similarly. Within the patient group, the correlation between acute mood improvement during challenge and greater metabolic suppression approached significance.
CONCLUSIONS: In familial mood disorders, a ventromedial prefrontal cortical deficit in baseline metabolism is not due to altered structural volume, and the response to serotonergic challenge appears predictive of acute mood response. The potential to predict treatment response can be tested by a combined challenge and treatment study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505804     DOI: 10.1176/appi.ajp.160.1.76

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

Review 1.  [Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy].

Authors:  O Moeller; C Norra; G Gründer
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

2.  Evidence for frontal-subcortical circuit abnormalities in bipolar affective disorder.

Authors:  William R Marchand; Pamela J Bennett; Dott Ssa Valentina Dilda
Journal:  Psychiatry (Edgmont)       Date:  2005-04

3.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

4.  Future suicide attempt and responses to serotonergic challenge.

Authors:  John G Keilp; Maria A Oquendo; Barbara H Stanley; Ainsley K Burke; Thomas B Cooper; Kevin M Malone; J John Mann
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

Review 5.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

Review 6.  Neurocircuitry of mood disorders.

Authors:  Joseph L Price; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 7.  The subgenual anterior cingulate cortex in mood disorders.

Authors:  Wayne C Drevets; Jonathan Savitz; Michael Trimble
Journal:  CNS Spectr       Date:  2008-08       Impact factor: 3.790

Review 8.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

9.  Reduced subgenual cingulate volumes in mood disorders: a meta-analysis.

Authors:  Tomas Hajek; Jiri Kozeny; Miloslav Kopecek; Martin Alda; Cyril Höschl
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

10.  Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression.

Authors:  M Elizabeth Sublette; Matthew S Milak; Joseph R Hibbeln; Peter J Freed; Maria A Oquendo; Kevin M Malone; Ramin V Parsey; J John Mann
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-01-06       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.